Pharmacy Medical News about Herpes Zoster

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
PharmacoEconomics, 09/23/09

White RR et al. – Based on the results from the present study, the direct medical cost burden of HZ in the US is high, exceeding $US1000 per HZ patient. This direct medical cost may be nearly twice as high in immunocompromised patients and four times as high in the subset of HZ cases with PHN. The direct medical cost burden of HZ may exceed $US1 billion annually in the US. The majority of medical RU and cost burden is incurred by the elderly. Although many people with HZ may no longer be in the workforce, HZ does contribute to lost work time.

<< Previous
Antifungal Activity of Micafungin in Serum

Next >>
Evidence-Based Treatment Options for the Management of Skin...

Increased Risk of Stroke After a Herpes Zoster Attack. A Population-Based Follow-Up Study
Stroke, 10/12/09 Relevance Score: 68%

Cutaneous Herpes Zoster and Implantable Pulse Generator
Neuromodulation, 11/02/09 Relevance Score: 67%

Epidemiological Features and Costs of Herpes Zoster in Taiwan: a National Study 2000 to 2006
Acta Dermato-Venereologica, 10/27/09 Relevance Score: 67%

A 9 year follow up of post herpetic neuralgia and predisposing factors in elderly patients following herpes zoster
Journal of Infection, 10/12/09 Relevance Score: 67%

Herpes zoster ophthalmicus
Expert Review of Ophthalmology, 10/08/09 Relevance Score: 67%